MedPath

Juniper Pharmaceuticals, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:2
Phase 3:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)โ€ข Click on a phase to view related trials

Phase 2
2 (50.0%)
Phase 3
2 (50.0%)

COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

Phase 2
Completed
Conditions
Endometrial Biopsy
Interventions
Drug: Placebo
First Posted Date
2015-06-08
Last Posted Date
2016-07-13
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
187
Registration Number
NCT02465320
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Futura Research, Norwalk, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Bluebird Clinical Trials, Colorado Springs, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Red Rocks OB/GYN, Lakewood, Colorado, United States

and more 20 locations

Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)

Phase 2
Completed
Conditions
Dysmenorrhea
Interventions
Drug: Placebo
First Posted Date
2008-04-02
Last Posted Date
2012-02-17
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
81
Registration Number
NCT00651313
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Lyndhurst Gynecologic Associates, Winston-Salem, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

SCIREX Research Center, Austin, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Jean Brown Research, Salt Lake City, Utah, United States

PREGNANT Short Cervix Trial

Phase 3
Completed
Conditions
Preterm Delivery
Short Cervix
Short Uterine Cervical Length
Interventions
Drug: placebo
First Posted Date
2008-02-14
Last Posted Date
2012-03-13
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
465
Registration Number
NCT00615550
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of South Alabama Dept. of OB/GYN, Mobile, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

St. Joseph's Hospital and Med Ctr Women's Care Center, Phoenix, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCI Medical Center, Orange, California, United States

and more 46 locations

Vaginal Progesterone to Reduce the Risk of Another Preterm Birth

Phase 3
Completed
Conditions
Pregnancy
Interventions
Drug: Placebo Vaginal Gel
First Posted Date
2004-06-29
Last Posted Date
2010-08-19
Lead Sponsor
Juniper Pharmaceuticals, Inc.
Target Recruit Count
636
Registration Number
NCT00086177
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of South Alabama Department of OBGYN, Mobile, Alabama, United States

๐Ÿ‡บ๐Ÿ‡ธ

Visions Clinical Research-Tucson, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Women's Health Department, Colton, California, United States

and more 42 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

ยฉ 2025 MedPath, Inc. All rights reserved.